Treatment with a Small Molecule Mutant IDH1 Inhibitor Suppresses Tumorigenic Activity and Decreases Production of the Oncometabolite 2-Hydroxyglutarate in Human Chondrosarcoma Cells

Luyuan Li(Nankai University), Jonathan C. Trent(The University of Texas MD Anderson Cancer Center)

PLoS ONE

September 14, 2015

10.1371/journal.pone.0133813

Cited by 106

Related Papers

Rare incidence of congestive heart failure in gastrointestinal stromal tumor and other sarcoma patients receiving imatinib mesylate

|Cancer|2009|80

Early effects of imatinib mesylate on the expression of insulin‐like growth factor binding protein‐3 and positron emission tomography in patients with gastrointestinal stromal tumor

|Cancer|2006|36

TNFSF15 suppresses VEGF production in endothelial cells by stimulating miR-29b expression<i>via</i>activation of JNK-GATA3 signals

|Oncotarget|2016|29